Join us in Washington, DC on Saturday, October 10 for #DCLung26 - a 1-day, comprehensive, @IASLC endorsed, multidisciplinary, discussion-based lung cancer CME update! From trainee to seasoned professional, MD to RN, local or not - something for everyone!
https://t.co/EGGHrShOsF
🫁 With the first Presidential Symposium of #WCLC26 filled with updates on SCLC, @StephenVLiu joined us on site to weigh in on the data & unpack the clinical implications of the MAVERICK, ARTEMIS-008, and TAISHAN-302 trials.
➡️ Watch: https://t.co/iSRbfWtpYy
#SCLC
ESMO is pleased to announce the #ESMOAmbassadors for #ESMO26.
They will share scientific highlights, expert perspectives and insights on the latest research presented at #ESMO26 across tumour types and disciplines.
🔗Discover the Ambassadors: https://t.co/bNrEAdOETz
Join us in Washington, DC on Saturday, October 10 for #DCLung26 - a one-day, comprehensive, multidisciplinary, discussion-based lung cancer CME update! Dr. @kaushalpar moderates our session on SCLC, mesothelioma, and thymic cancers. Grab your spot now!
https://t.co/gD0mjDfpYw
ESMO is pleased to announce the #ESMOAmbassadors for #ESMO26.
They will share scientific highlights, expert perspectives and insights on the latest research presented at #ESMO26 across tumour types and disciplines.
🔗Discover the Ambassadors: https://t.co/bNrEAdOETz
5y follow up from phase II study of lorlatinib in ALK+ NSCLC @JTOonline. Shorter OS noted for EML4::ALK fusion variant 3 competed to variants 1 or 2 and with TP53 co-mutation.
https://t.co/mI999bgtca
Join us in Washington, DC on Saturday, October 10 for #DCLung26 - a 1-day, comprehensive, @IASLC endorsed, multidisciplinary, discussion-based lung cancer CME update! From trainee to seasoned professional, MD to RN, local or not - something for everyone!
https://t.co/EGGHrShOsF
🫁 What's the latest on ADAURA?
🌟 Don't miss this insightful interview with @DrRoyHerbst of @DartmouthCancer, who joined us at #WCLC26 to unpack the 8-year data he presented at the Presidential Symposium!
➡️ Watch: https://t.co/I2p7fqTGDm
#lcsm#EGFR#NSCLC
Something we’ve been working on for some time…
🎬 Our Lungs: Time to Breathe
Last week we held the first screening of our new documentary, commissioned by EGFR Positive Lung Cancer UK.
The response was incredibly powerful.
A film about challenging perceptions, earlier diagnosis and why lung cancer can affect anyone.
More to come.
#EGFRPositive #LungCancer
📸 Raphael Neal 🙏
@ests_womenThor@pompili_cecilia@IASLC Dr. Pompili is a tireless and fierce advocate for our patients, refocusing research on patient outcomes and giving patients a strong voice. Glad to see recognition for her drive, passion, innovation, and persistence. Inertia is hard to overcome. Congratulations @pompili_cecilia
Congratulations to @pompili_cecilia, recipient of the 2026 Robert J. Ginsberg Lectureship Award for Surgery from the @IASLC at #WCLC26 in Seoul 🇰🇷
As founder of the WGTS Academy, her work has shaped mentorship for women in thoracic surgery worldwide. Well deserved.
Join us in Washington, DC on Saturday, October 10 for #DCLung26 - a one-day, comprehensive, multidisciplinary, discussion-based lung cancer CME update! Dr. @KeiSuzukiMD joins the discussion on state of the art surgery for early stage NSCLC!
https://t.co/gD0mjDeS8Y
I'm excited/nervous to describe 'My life with #lungcancer' to open this great conference, in less than a month. I'll be speaking to researchers & leading oncologists (including my own, who've helped keep me cancer-free since 2023, 5 months after being diagnosed w stage 4.)
PAPILLON (NCT04538664) final OS: 34.3 vs 27.9 months (ITT HR, 0.87, not significant amid 76% crossover). Crossover-adjusted (IPCW): HR 0.57, a 43% lower risk of death with amivantamab-chemo in EGFR exon 20 insertion+ NSCLC @IASLC@chulkimMD@LombardiCancer#WCLC26#lcsm https://t.co/8PpnaOe2DU
The World Conference on Lung Cancer is the world’s largest multidisciplinary meeting dedicated to thoracic malignancies – and we'll be talking about the news from the event at our October 7 Together Separately livestream. Learn more and RSVP at https://t.co/FVjLrmn4hH. #LungCancer #WCLC26